HYPERBARIC OXYGEN THERAPY FOR Alzheimer's disease
Hyperbaric oxygen therapy (HBOT) is an alternative treatment option that has been studied for its potential to help those suffering from Alzheimer's disease. It involves the use of pressurized oxygen chambers that are designed to provide a higher concentration of oxygen than can be found in normal atmospheric air. This increased oxygen delivery helps to improve cellular health and energy production, which can lead to improved cognition, memory, and behavior in Alzheimer’s patients.
Several studies have been conducted on the use of HBOT for Alzheimer's disease that suggest it may be beneficial for addressing some of the most common symptoms associated with dementia. One study found that after 12 weeks of daily 60-minute HBOT sessions, Alzheimer's patients had improved cognition, memory, and behavior.[1]
Additionally, there is evidence that suggests HBOT may help to slow the progression of the disease itself. In one study, those with mild to moderate Alzheimer's who underwent daily 90-minute HBOT sessions for 10 weeks showed a significant decrease in cognitive decline compared to those who did not receive HBOT.[2]
In short, hyperbaric oxygen therapy shows promise as an alternative treatment option for Alzheimer's disease and may help improve cognitive function, memory, behavior, and slow the progression of the disease itself. If you are considering this treatment for yourself or a loved one, it is important to discuss it with your doctor to ensure it is the right option for you.
We hope this information has been helpful in understanding the potential of hyperbaric oxygen therapy for Alzheimer's disease.
Contact Thrive Hyperbarics today.
References:
[1] Marcinkowska AB, Mankowska ND, Kot J, Winklewski PJ. Impact of Hyperbaric Oxygen Therapy on Cognitive Functions: a Systematic Review. Neuropsychol Rev. 2022 Mar;32(1):99-126. doi: 10.1007/s11065-021-09500-9. Epub 2021 Apr 13. PMID: 33847854; PMCID: PMC8888529.
[2] Hachmo Y, Hadanny A, Abu Hamed R, Daniel-Kotovsky M, Catalogna M, Fishlev G, Lang E, Polak N, Doenyas K, Friedman M, Zemel Y, Bechor Y, Efrati S. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). 2020 Nov 18;12(22):22445-22456. doi: 10.18632/aging.202188. Epub 2020 Nov 18. PMID: 33206062; PMCID: PMC7746357.